Systemic sulfonamides are contraindicated during late pregnancy<span>, lactation, and in ... ARF is </span>rarely<span> associated with newer sulfonamides, which are more soluble ... is the drug of choice </span>because it can<span> be given to </span>patients<span> with renal impairment, ...</span>
Answer:
By preventing the binding of substrate to active site
Explanation:
Competitive inhibitors exhibit a type of reversible inhibition. These are the substances that bind to the binding site of the substrate on the enzyme, that is the active site.
One the competitive inhibitor is bound to the active site on the enzyme, the substrate cannot bind to it and there is no enzyme-substrate complex formation. Hence, the competitive inhibitor inhibits/slow down the enzyme catalysis by occupying the active site of the enzyme and thereby not allowing the substrate to bind to the enzyme.
Answer:
Is there more to the question? I'm not sure what this would be.
The Hershey and Chase experiment concluded the same by labeling the DNA of the parents with phosphorous and found out that the DNA of the offspring also bear phospho- labeled DNA, which established the fact that DNA is the heritable information source. So, your answer is B.
Ans.
Hypothyroidism is a thyroid disorder, in which thyroid gland cannot produce enough thyroid hormones needed by body. It is characterized by weight gain, slow heart rate, and intolerance to cold as thyroid hormone is responsible for increased metabolism and provides heat tolerance.
So, the patient is suffering from hypothyroidism as given symptoms are characteristics of hypothyroidism. Levothyroxine is a medicine, similar to natural thyroid hormones and is used for the treatment of hypothyroidism.
Thus, the correct answer is 'levothyroxine.'
